Lupin exceeded profit expectations in the second quarter, reporting a 74% surge in profits, reaching ₹8.53 billion. This growth was fueled by robust demand for their respiratory and diabetes medications. Overall revenue also saw an 11.3% increase, reaching ₹54.97 billion.
Berkshire Hathaway spends down cash pile under CEO Greg Abel
Berkshire Hathaway reduced its cash hoard to $365.5 billion in Q2, as CEO Greg Abel deployed capital into $4.5 billion of stock buybacks and nearly